Thorne HealthTech, Inc. (NASDAQ:THRN) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET
Company Participants
Thomas Wilson - Vice President, Investor Relations
Paul Jacobson - Chief Executive Officer
Bryan Conley - Chief Financial Officer
Michelle Crow - Chief Marketing Officer
Conference Call Participants
Elizabeth Anderson - Evercore
Sean Dodge - RBC Capital Markets
Max Rakhlenko - Cowen and Co.
Operator
Welcome to the Thorne HealthTech Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] Thank you.
Now, let me turn the call over to Thomas Wilson, Vice President of Investor Relations. So, Thomas you may begin.
Thomas Wilson
Good morning, everyone. Thank you for joining Thorne HealthTech's Third Quarter 2022 Earnings Call. With me today to share our results are Paul Jacobson, our CEO; and Bryan Conley, our CFO. Tom McKenna, our COO; and Michelle Crow, our CMO are also available for questions.
Before we begin, please note that today's discussion contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those indicated by our forward-looking statements. More information about potential risk factors can be found in our 2021 Annual Report on Form 10-K, and our upcoming Form 10-Q, which we anticipate filing after market today and in other SEC filings.
Today in addition with US GAAP reporting, we will be discussing financial measures that do not conform to GAAP. We believe these non-GAAP measures enhance the understanding of our performance because they are more representative of how we internally measure the business.
Non-GAAP financial measures should not be considered in isolation from or as a substitute for GAAP measures. A reconciliation of GAAP to non-GAAP results is available in the earnings press release we issued after market closed yesterday and in the supplemental investor presentation posted to our IR website.
Finally, in three weeks, we will be participating in the Evercore ISI HealthCONx Conference and holding investor meetings. A webcast of the event will be accessible on our IR site, and we look forward to meeting with you.
With that, I'll turn the call over to Paul.
Paul Jacobson
Thank you, Thomas. Good morning, everyone. Thank you for joining our third quarter earnings call today. I'll summarize our strong financial performance for Q3, with record sales and strong profitability discuss how our consumers are holding up in the current environment, step through a handful of recent developments and opportunities on the testing and R&D sides of our business, and round out my prepared remarks with our outlook to close out 2022. Bryan will provide further discussion of our Q3 performance and capital deployment in his prepared remarks. Lastly, additional details can be found in the earnings release and supplemental investor presentation that we issued after the market closed yesterday.